Clinical Trials

Neoplasms

NCT06623656 2025-10-23

Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC

Phase 2 Recruiting

112 enrolled

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT06463665 2025-09-26

VIRO-25

Phase 2 Recruiting

142 enrolled

Phase 2 Active not recruiting

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Vaccinia

NCT06632951 2025-08-11

LIVIGNO-3

150 enrolled

Carcinoma, Transitional Cell, Neoplasms

NCT03739710 2025-06-15

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)

175 enrolled 5 charts

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT03951831 2025-04-25

REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer

26 enrolled

Neoplasms, Prostatic Neoplasms

NCT03837977 2024-12-30

NET02

58 enrolled

Endocrine

Neoplasms, Carcinoma, Neuroendocrine

NCT00587431 2023-11-07

Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer

102 enrolled 8 charts

Neoplasms, Prostatic Neoplasms

NCT00020046 2023-10-31

Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer

Neoplasms, Prostatic Neoplasms, Genetic Diseases, Inborn

NCT02126969 2023-03-13

A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN

45 enrolled 13 charts

Head & Neck

Head and Neck Neoplasms, Laryngeal Diseases, Neoplasms

NCT05553808 2023-01-19

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1

105 enrolled 31 charts

Neoplasms

NCT00206518 2020-07-28

TACAC

167 enrolled 10 charts

Breast Neoplasms, Neoplasms

NCT02403531 2020-06-02

Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer

110 enrolled

Esophageal Neoplasms, Neoplasms

NCT02117024 2020-02-05

A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

66 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT01869192 2019-09-24

Phase II Trial for Large ER-Negative Breast Cancers

72 enrolled 6 charts

Neoplasms

NCT00979641 2019-03-28

AINO

65 enrolled

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT01376310 2019-02-19

GSK1120212 Rollover Study

159 enrolled 9 charts

Neoplasms

NCT00089609 2018-04-20

Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer

73 enrolled 16 charts

Neoplasms, Prostatic Neoplasms

NCT01888978 2018-04-09

Molecularly Tailored Therapy for Pancreas Cancer

19 enrolled

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT02474186 2017-08-03

Phase II Study for Solid Metastatic Tumors

41 enrolled

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00226239 2017-07-11

Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer

39 enrolled 10 charts

Neoplasms

NCT00591149 2017-06-14

Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer

16 enrolled 5 charts

Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms, Neoplasms, Squamous Cell

NCT01472146 2017-05-09

ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer

58 enrolled

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site

NCT00741195 2016-10-04

Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung Cancer

50 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00177255 2016-02-08

A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers

40 enrolled 6 charts

Neoplasms

NCT00755157 2015-10-07

Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer

Phase 2 Withdrawn

Neoplasms, Small Cell Lung Carcinoma

NCT00758732 2015-09-28

Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma

34 enrolled

Gynecologic

Neoplasms, Ovarian Neoplasms

NCT01754623 2015-08-13

GTX-RT in Borderline Resectable Pancreatic Cancer

9 enrolled 7 charts

Neoplasms, Pancreatic Neoplasms

NCT00660699 2015-05-27

A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers

50 enrolled 21 charts

Gallbladder Neoplasms, Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma

NCT00557206 2013-11-05

Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

35 enrolled

Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence

NCT01338753 2013-09-10

IMAGING

74 enrolled

Breast Neoplasms, Neoplasms

NCT00206453 2013-02-05

Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer

25 enrolled

Breast Neoplasms, Neoplasms

NCT00453635 2012-03-13

Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients

88 enrolled

Breast Neoplasms, Neoplasms

NCT00206466 2012-01-25

TAX/AC

70 enrolled

Breast Neoplasms, Neoplasms

NCT01083589 2012-01-11

Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC)

22 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00206505 2011-11-17

Neoadjuvant Taxotere

40 enrolled

Breast Neoplasms, Neoplasms

NCT00031187 2011-10-24

Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer

160 enrolled

Neoplasms, Prostatic Neoplasms

NCT00356122 2011-10-17

Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)

53 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Recurrence

NCT00232206 2011-05-18

Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer

40 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT00544960 2010-08-27

A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer

106 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00415285 2007-02-13

Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer

Phase 2 Unknown

100 enrolled